New organ allocation policy in liver transplantation in the United States
David A. Goldberg, Richard Gilroy, Michael Charlton – 27 October 2016
Natural history of nonalcoholic steatohepatitis/nonalcoholic fatty liver disease‐hepatocellular carcinoma: Magnitude of the problem from a hepatology clinic perspective
Delia D'Avola, Ismail Labgaa, Augusto Villanueva – 27 October 2016
New pharmacological approaches to a functional cure of hepatitis B
Wai‐Kay Seto, Man‐Fung Yuen – 27 October 2016
Natural history of nonalcoholic steatohepatitis–associated hepatocellular carcinoma
Stefano Bellentani, Gianluca Svegliati Baroni, Fabio Piscaglia, Claudio Tiribelli – 27 October 2016
The transition from inflammation to cancer in the liver
Augusto Villanueva, Tom Luedde – 27 October 2016
New pharmacological approaches to a functional cure of hepatitis B
Wai‐Kay Seto, Man‐Fung Yuen – 27 October 2016
Liver fibrosis: Which mechanisms matter?
Ralf Weiskirchen, Frank Tacke – 27 October 2016
Natural history of nonalcoholic steatohepatitis–associated hepatocellular carcinoma
Stefano Bellentani, Gianluca Svegliati Baroni, Fabio Piscaglia, Claudio Tiribelli – 27 October 2016
Portal hypertensive bleeding in cirrhosis: Risk stratification, diagnosis, and management: 2016 practice guidance by the American Association for the study of liver diseases
Guadalupe Garcia‐Tsao, Juan G. Abraldes, Annalisa Berzigotti, Jaime Bosch – 27 October 2016
Meeting Notices
26 October 2016